NASDAQ:DRIO

DarioHealth Insider Trades

$13.84
+0.17 (+1.24 %)
(As of 09/23/2021 12:00 AM ET)
Add
Compare
Today's Range
$13.25
$14.02
50-Day Range
$10.47
$16.64
52-Week Range
$10.01
$31.85
Volume77,508 shs
Average Volume256,163 shs
Market Capitalization$228.48 million
P/E RatioN/A
Dividend YieldN/A
Beta1.32

DarioHealth (NASDAQ:DRIO) Insider Buying and Selling Activity

14.10% of DarioHealth's shares are owned by company executives, directors and other insiders. Over the past twelve months, DarioHealth insiders have sold shares 4 time(s), totalling $1,083,831.54. Insiders that have sold shares include Erez Raphael, Dror Bacher, and Dennis M Mcgrath.

Insider Buying and Selling by Quarter


DarioHealth (NASDAQ DRIO) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/15/2021Erez RaphaelCEOSell1,300$17.63$22,919.00943,299  
7/6/2021Dror BacherCOOSell2,479$20.32$50,373.28  
7/2/2021Dror BacherCOOSell11,021$20.63$227,363.23186,278  
5/26/2021Dennis M McgrathDirectorSell45,773$17.11$783,176.0351,630  
6/9/2020Erez RaphaelCEOBuy1,000$6.05$6,050.00
3/25/2020Erez RaphaelCEOBuy1,000$6.50$6,500.00
3/20/2020Adam K SternDirectorBuy14,500$4.35$63,075.00
8/28/2019Erez RaphaelCEOBuy10,000$0.35$3,500.00  
8/16/2019Yoav ShakedDirectorBuy12,888$0.45$5,799.60  
11/27/2018Allen KamerDirectorBuy6,000$0.75$4,500.00  
11/21/2018Yoav ShakedDirectorBuy1,500$0.94$1,410.00  
11/20/2018Erez RaphaelCEOBuy4,000$0.84$3,360.00  
11/19/2018Hila KarahDirectorBuy5,000$0.70$3,500.00  
9/13/2018Yoav ShakedDirectorBuy12,376$0.90$11,138.40  
2/28/2018Zvi Ben-DavidCFOBuy9,018$1.40$12,625.20  
8/19/2016Erez RaphaelCEOBuy500$3.57$1,785.00111,129  
(Data available from 1/1/2013 forward)
speech bubbles
speech bubbles











DarioHealth (NASDAQ:DRIO) Insider Trade Frequently Asked Questions

Who is on DarioHealth's Insider Roster?

The list of insiders at DarioHealth includes Adam K Stern, Allen Kamer, Dennis M Mcgrath, Dror Bacher, Erez Raphael, Hila Karah, and Yoav Shaked.Learn more on DRIO's insiders

What percentage of DarioHealth stock is owned by insiders?

14.10% of DarioHealth stock is owned by insiders. Learn more on DRIO's insider holdings

Which DarioHealth insiders have been buying company stock?

The following insiders have purchased DarioHealth stock in the last 24 months: Adam K Stern ($63,075.00), and Erez Raphael ($12,550.00).

How much insider buying is happening at DarioHealth?

Insiders have purchased a total of 16,500 DarioHealth shares in the last 24 months for a total of $75,625.00 bought.

Which DarioHealth insiders have been selling company stock?

The following insiders have sold DarioHealth stock in the last 24 months: Dennis M Mcgrath ($783,176.03), Dror Bacher ($277,736.51), and Erez Raphael ($22,919.00).

How much insider selling is happening at DarioHealth?

Insiders have sold a total of 60,573 DarioHealth shares in the last 24 months for a total of $1,083,831.54 sold.

This page was last updated on 9/24/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.